Evaluation of renal function in liver transplant recipients receiving daclizumab (zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

Eric M. Yoshida, Paul J. Marotta, Paul D. Greig, Norman M. Kneteman, Denis Marleau, Marcelo Cantarovich, Kevork M. Peltekian, Leslie B. Lilly, Charles H. Scudamore, Vincent G. Bain, William J. Wall, Andre Roy, Robert F. Balshaw, Jeffrey S.T. Barkun

Résultat de recherche: Articleexamen par les pairs

132 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'Evaluation of renal function in liver transplant recipients receiving daclizumab (zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial'. Ensemble, ils forment une empreinte numérique unique.

Medicine & Life Sciences